Mixed chimeric hematopoietic stem cell transplant reverses the disease phenotype in canine leukocyte adhesion deficiency.
Academic Article
Overview
Research
Identity
Additional Document Info
Other
View All
Overview
abstract
The genetic disease canine leukocyte adhesion deficiency (CLAD) is characterized by recurrent, severe bacterial infections, typically culminating in death by 6 months of age. CLAD is due to a mutation in the leukocyte integrin CD18 subunit, which prevents surface expression of the CD11/CD18 leukocyte integrin complex. We demonstrate that stable mixed donor:host hematopoietic chimerism, achieved by a non-myeloablative bone marrow transplant from a histocompatible littermate, reverses the disease phenotype in CLAD. Donor chimerism following the transplant was demonstrated both by flow cytometric detection of donor-derived CD18-positive leukocytes in the peripheral blood of the recipient, and by the demonstration of donor-derived DNA microsatellite repeats in the peripheral blood leukocytes of the recipient. These results indicate that mixed hematopoietic chimerism reverses the clinical phenotype in CLAD and represents a potential therapeutic approach for the human disease leukocyte adhesion deficiency.
Creevy, K. E., Bauer, T. R., Tuschong, L. M., Embree, L. J., Silverstone, A. M., Bacher, J. D., ... Hickstein, D. D.
citation count
23
complete list of authors
Creevy, Kate E||Bauer, Thomas R||Tuschong, Laura M||Embree, Lisa J||Silverstone, Andrew M||Bacher, John D||Romines, Chris||Garnier, Julie||Thomas, Marvin L||Colenda, Lyn||Hickstein, Dennis D